| |
Summarized by Won-Jang Kim, MD (Asan Medical
Center) |
| 1. |
AVIO: A Prospective, Randomized Trial
of Intravascular-Ultrasound Guided Compared to Angiography Guided Stent
Implantation in Complex Coronary Lesions
Source: Presented by Antonio Colombo at: TCT 2010 |
| 2. |
BioFreedom: A Prospective Randomized Trial of
Polymer-Free BiolimusA9-Eluting Stents and Paclitaxel-Eluting Stents
in Patients with Coronary Artery Disease
Source: Presented by Eberhard Grube at: TCT 2010 |
| 3. |
The BLAST Trial: Biorest Liposomal Alendronate
with Stenting sTudy
Source: Presented by Montalescot, Gilles at: TCT 2010 |
| 4. |
Compare Trial: 2 year follow-up
Source: Presented by Peter Smits at: TCT 2010 |
| 5. |
CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting
Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting
Coronary Stents
Source: Presented by Bernard Chevalier at: TCT 2010 |
| 6. |
DES-BTK: A Prospective, Double-Blind Randomized
Trial of Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal
Stents in Patients with Infrapopliteal Disease
Source: Presented by Aljoscha Rastan at: TCT 2010 |
| 7. |
EXCELLENT: Efficacy of Xience/Promus versus Cypherto
rEduce Late Loss in stent
Source: Presented by Hyo-Soo Kim at: TCT 2010 |
| 8. |
A Prospective, Multicenter Randomized Trial of
Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin, and Drug-eluting
vs. Bare Metal Stents in ST-Segment Elevation Myocardial Infarction:
Final Reportfrom the HORIZONS-AMI Trial
Source: Presented by Gregg W. Stone at: TCT 2010 |
| 9. |
A Prospective, Multicenter Randomized Trial of
Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin, and Drug-eluting
vs. Bare Metal Stents in ST-Segment Elevation Myocardial Infarction:
Final Reportfrom the HORIZONS-AMI Trial
Source: Presented by Gregg W. Stone at: TCT 2010 |
| 10. |
The Safety and Tolerability of Atopaxar(E5555)
in the Treatment of Patients with Acute Coronary Syndromes: The LANCELOT-ACS
Trial
Source: Presented by Michelle O’Donoghue at: TCT 2010 |
| 11. |
The Safety and Tolerability of Atopaxar(E5555)
in the Treatment of Patients with Acute Coronary Syndromes: The LANCELOT-ACS
Trial
Source: Presented by Michelle O’Donoghue at: TCT 2010 |
| 12. |
TranscatheterAortic Valve Implantation in Inoperable
Patients with Severe Aortic Stenosis
Source: Presented by Martin B. Leon at: TCT 2010 |
| 13. |
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting
Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring
Stents for De Novo Coronary Artery Disease: PERfECT Stent Study
Source: Presented by Jochen Wöhrle at: TCT 2010 |
| 14. |
A Prospective, Randomized Trial of Everolimus-Eluting
and Sirolimus-Eluting Stentsin Patients with Coronary Artery Disease:
The SORT OUT IV Trial
Source: Presented by Lisette Okkels Jensen at: TCT 2010 |
| 15. |
A Large-Scale Randomized Comparison of Everolimus-Eluting
and Paclitaxel-Eluting Stents: Two-Year Clinical Outcomes from the SPIRIT
IV Trial
Source: Presented by Gregg W. Stone at: TCT 2010 |
| 16. |
Thrombus Obliteration by Rapid Percutaneous Endovenous
Intervention in Deep Venous Occlusion “TORPEDO” trial :
Mid –Term results
Source: Presented by TORPEDO at: TCT 2010 |
| 17. |
The Zilver PTX Randomized Trial: 12-month Results
of a Paclitaxel-Eluting StentVersus Balloon Angioplasty and Bare Metal
Stentingin Patients with Femoropopliteal Artery Disease
Source: Presented by Michael D. Dake at: TCT 2010 |
